Skip to main
NNNN

NNNN P/E Ratio

P/E Ratio as of Jan 9, 2026: 553.64

Average514.93
Median513.21
Minimum462.21
Maximum591.42
553.64
27.65 (5.26%)past month
The P/E ratio for NNNN is 553.64 as of Jan 9, 2026. This represents a increase of 64.53% compared to its 12-month average P/E ratio of 336.49. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Anbio Biotechnology Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Anbio Biotechnology Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Anbio Biotechnology Ltd to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NNNN P/E Ratio Historic Data

DateStock priceP/E ratio
Dec 1, 2025$26.75441.42
Nov 3, 2025$12.29202.81
Oct 1, 2025$34.92576.24
Sep 2, 2025$45.65753.30
Aug 1, 2025$42.80706.27
Jul 1, 2025$31.44518.81
Jun 2, 2025$7.915130.61
May 1, 2025$6.29103.80
Apr 1, 2025$7.2768.20
Mar 18, 2025$6.9069.98

NNNN End of Year P/E Ratio

DateP/E ratioChange
2026553.64+16.36%
2025475.79

FAQs About Anbio Biotechnology Ltd (NNNN) P/E ratio

The latest P/E ratio of NNNN is 553.64, as of Jan 9, 2026. This is calculated based on its current stock price and earnings per share (EPS).

Anbio Biotechnology Ltd’s last 12-month average P/E ratio is 336.49, compared to its current P/E ratio of 553.64. This reflects a increase of 64.53%.

Anbio Biotechnology Ltd’s current P/E ratio of 553.64 is higher than its last 12-month average P/E of 336.49. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Anbio Biotechnology Ltd’s average P/E ratio over the last 3 years is 112.16. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Anbio Biotechnology Ltd’s average P/E ratio over the last 5 years is 67.3. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Anbio Biotechnology Ltd (NNNN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.